Cancer Study Points to Tighter Pairing of Drugs and Patients

The first large and comprehensive study of the genetics of a common lung cancer has found that more than half the tumors from that cancer have mutations that might be treated by new drugs that are already in the pipeline or that could be easily developed.
The New York Times